The domestic equities witnessed strong start to the day's trading session on Wednesday. IT and pharma led the upmove. The Nifty traded above 16,100 level.
At 9:30 IST, the barometer index, the S&P BSE Sensex, rose 405 points or 0.76% at 53,829.09. The Nifty 50 index gained 116.40 points or 0.73% at 16,129.85.
In the broader market, the S&P BSE Mid-Cap index added 0.96% while the S&P BSE Small-Cap index rose 1.25%.
The market breadth was strong. On the BSE, 2,187 shares rose and 437 shares fell. A total of 78 shares were unchanged.
Foreign portfolio investors (FPIs) sold shares worth Rs 8,142.60 crore, while domestic institutional investors (DIIs), were net buyers to the tune of Rs 6,489.59 crore in the Indian equity market on 8 March 2022, provisional data showed.
LIC IPO Update:
State-owned insurance behemoth Life Insurance Corporation of India (LIC) on Tuesday has reportedly received capital markets regulator Sebi's go-ahead to raise funds through an initial share sale. The government will sell over 31 crore equity shares of LIC.
Stocks in Spotlight:
Sun Pharmaceutical Industries advanced 2.05%. The company's subsidiary Taro Pharmaceuticals USA Inc has completed the acquisition of subsidiary companies of Galderma.
Bharat Forge rose 0.71%. The auto ancillary company said its subsidiary Kalyani Strategic Systems (KSSL) has incorporated a company - Sagar-Manas Technologies (SMTL) on 7 March 2022 as a wholly owned subsidiary.
ISGEC Heavy Engineering rallied 3.92%. Isgec has received an order from Shree Cement for Cement Waste Heat Recovery Boilers for their 3.8 MTPA (million tonnes per annum) clinker capacity, integrated Cement Plant at Nawalgarh, District Jhunjhunu, Rajasthan.
Zydus Lifesciences gained 4.22%. Sentynl Therapeutics Inc., a wholly owned subsidiary of Zydus Lifesciences and BridgeBio Pharma announced asset purchase agreement for BridgeBio Pharma's NULIBRY (Fosdenopterin).
Global Markets:
Asian stocks traded mixed on Wednesday, recovering partially from losses earlier in the week as investors continue to assess the potential economic ramifications of the ongoing war in Ukraine. Markets in South Korea are closed on Wednesday due to the country's presidential election.
Japan's economic rebound was softer than initial estimates in the final quarter of 2021, revised data showed on Wednesday. Revised gross domestic product (GDP) data showed Japan expanded an annualised 4.6% in October-December. That was lower than the preliminary reading of 5.4% released last month.
Oil prices jumped to their session highs on Tuesday after President Joe Biden said the U.S. will ban imports of Russian oil, a further escalation in the international response to Moscow's invasion of Ukraine. The United Kingdom also announced its own plans to phase out its reliance on Russian oil imports by the end of the year.
US stocks declined on Tuesday as investors continue to assess geopolitical tensions between Russia and Ukraine and high commodity prices.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU